Free Trial

Repare Therapeutics (RPTX) News Today

$3.48
-0.07 (-1.97%)
(As of 07/12/2024 ET)
Repare Therapeutics logo with Medical background
Repare Therapeutics Inc. (NASDAQ:RPTX) Short Interest Update
Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 865,200 shares, a growth of 51.1% from the June 15th total of 572,600 shares. Based on an average daily volume of 239,100 shares, the short-interest ratio is currently 3.6 days. Approximately 3.0% of the company's shares are short sold.
Repare Therapeutics (NASDAQ:RPTX) Trading Down 0.3%
Repare Therapeutics logo with Medical background
Repare Therapeutics (NASDAQ:RPTX) Stock Price Down 0.3%
Repare Therapeutics (NASDAQ:RPTX) Stock Price Down 0.3%
Repare Therapeutics logo with Medical background
Q2 2024 Earnings Estimate for Repare Therapeutics Inc. (NASDAQ:RPTX) Issued By Capital One Financial
Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) - Capital One Financial upped their Q2 2024 earnings per share (EPS) estimates for shares of Repare Therapeutics in a research note issued on Wednesday, June 12th. Capital One Financial analyst T. Chiang now expects that the company will post e
Repare Therapeutics Inc. (NASDAQ:RPTX) Stock Holdings Lifted by BVF Inc. IL
BVF Inc. IL increased its position in shares of Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) by 24.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,333,600 shares of the company's stock after acqu
Repare Therapeutics Inc. Expected to Earn FY2028 Earnings of $0.35 Per Share (NASDAQ:RPTX)
Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) - Stock analysts at Capital One Financial boosted their FY2028 earnings estimates for shares of Repare Therapeutics in a report issued on Wednesday, June 12th. Capital One Financial analyst T. Chiang now anticipates that the company will post e
Repare Therapeutics Inc. (RPTX)
Repare Therapeutics Inc Ordinary Shares
Repare Therapeutics appoints new board member
Repare Therapeutics Appoints Steven H. Stein, M.D.
Repare Therapeutics (NASDAQ:RPTX) Rating Increased to Buy at Bloom Burton
Bloom Burton upgraded Repare Therapeutics from an "accumulate" rating to a "buy" rating in a research report on Friday.
RPTX Apr 2024 7.500 call
RPTX Jul 2024 7.500 call
Recap: Repare Therapeutics Q4 Earnings
RPTX Mar 2024 7.500 call
Repare Therapeutics Inc. (NASDAQ:RPTX) to Post Q2 2024 Earnings of ($0.96) Per Share, HC Wainwright Forecasts
Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) - Analysts at HC Wainwright dropped their Q2 2024 EPS estimates for Repare Therapeutics in a research report issued on Wednesday, February 14th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.96) per share
Get Repare Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.

This litigation is a blessing in disguise (Ad)

This may be one of the most bizarre situations I’ve ever seen. One stock on the NASDAQ is now trading for $10. What’s so unusual is that this company has a market cap of $8 billion and $9 billion in cash.

Review this information at your own leisure. You won’t be disappointed.

RPTX Media Mentions By Week

RPTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RPTX
News Sentiment

0.69

0.92

Average
Medical
News Sentiment

RPTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RPTX Articles
This Week

3

2

RPTX Articles
Average Week

Get Repare Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RPTX) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners